advertisement
11.4 Prostaglandins (57)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins81875 Does using topical latanoprost affect subfoveal choroidal thickness?
Duru Z
Cutaneous and Ocular Toxicology 2019; 38: 370-374
81926 Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs
Lee SS
Journal of Glaucoma 2019; 28: 846-857
82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Sinha S
Expert Opinion in Pharmacotherapy 2020; 21: 39-45
82775 Efficacy and safety of tafluprost 0.0015% - retrospective analysis of real-world data from the Philippines
Tumbocon JA
Clinical Ophthalmology 2019; 13: 1627-1634
82207 Effect of topical prostaglandins on the biomechanics and shape of the cornea
Amano S
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2213-2219
82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Yadav M
Data in brief 2019; 25: 104361
81819 Prospective randomized clinical trial on the effects of latanoprost, travoprost and bimatoprost on latanoprost non-responders
Blondeau P
Journal Français d'Ophtalmologie 2019; 42: 894-899
82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Topouzis F
European Journal of Ophthalmology 2019; 0: 1120672119878044
82074 Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film
Sedlak L
Medicina (Kaunas, Lithuania) 2019; 55:
82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Kumar S
Romanian journal of ophthalmology 2019; 63: 249-256
82048 Antiglaucoma EP Agonists: A Long Road That Led Somewhere
Woodward DF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 469-474
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82074 Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film
Zych M
Medicina (Kaunas, Lithuania) 2019; 55:
82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Singh T
Romanian journal of ophthalmology 2019; 63: 249-256
82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Guzman-Aranguez A
Data in brief 2019; 25: 104361
81819 Prospective randomized clinical trial on the effects of latanoprost, travoprost and bimatoprost on latanoprost non-responders
Hamid M
Journal Français d'Ophtalmologie 2019; 42: 894-899
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Lu F
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Lee D
Expert Opinion in Pharmacotherapy 2020; 21: 39-45
81926 Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs
Robinson MR
Journal of Glaucoma 2019; 28: 846-857
82775 Efficacy and safety of tafluprost 0.0015% - retrospective analysis of real-world data from the Philippines
Macasaet AM
Clinical Ophthalmology 2019; 13: 1627-1634
82048 Antiglaucoma EP Agonists: A Long Road That Led Somewhere
Wang JW
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 469-474
81875 Does using topical latanoprost affect subfoveal choroidal thickness?
Özsaygılı C
Cutaneous and Ocular Toxicology 2019; 38: 370-374
82207 Effect of topical prostaglandins on the biomechanics and shape of the cornea
Nejima R
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2213-2219
82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Goldberg I; Bell K
European Journal of Ophthalmology 2019; 0: 1120672119878044
81875 Does using topical latanoprost affect subfoveal choroidal thickness?
Ulusoy DM
Cutaneous and Ocular Toxicology 2019; 38: 370-374
